Switch to
More onapp

Strides Pharma Science Ltd

STAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,046 cr, stock is ranked 662
Moderate RiskStock is 2.49x as volatile as Nifty
349.806.30 (+1.83%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,046 cr, stock is ranked 662
Moderate RiskStock is 2.49x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
-6.62
PB RatioPB Ratio
1.28
Dividend YieldDiv. Yield
Sector PESector PE
35.90
Sector PBSector PB
4.36
Sector Div YldSctr Div Yld
0.88%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on development and manufacture of IP-led niche and pharmaceutical products. It operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as, liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Financial TrendFinancial statements 

20192020202120222.552.913.523.260.320.040.27-0.46
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 1.50%

See detailed holdings

Recent EventsAll events 

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 22, 2022

Strides Pharma Science Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Strides Pharma Science Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Press Release 
Announced OnNov 18, 2022

Strides Pharma Science Limited has informed the Exchange about press release dated 18-Nov-2022 titled Strides receives USFDA approval for Potassium Chloride Oral Solution | Download

Strides Pharma Science Limited has informed the Exchange about press release dated 18-Nov-2022 titled Strides receives USFDA approval for Potassium Chloride Oral Solution | Download

Cash Dividend 
Ex. DateAug 5, 2021

Final • Div/Share: ₹ 2.5

See all events